NASDAQ: ETONEton Pharmaceuticals Inc Stock Ownership - Who owns Eton Pharmaceuticals?
Insider buying vs selling
Have Eton Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Norbert G. Riedel | Director | 2026-04-21 | 19,655 | $8.61 | $169.23kBuy |
| Norbert G. Riedel | Director | 2026-04-21 | 12,500 | $7.31 | $91.38kBuy |
| Norbert G. Riedel | Director | 2026-02-03 | 30,000 | $4.42 | $132.60kBuy |
| James R. Gruber | Chief Financial Officer | 2026-01-14 | 2,293 | $15.47 | $35.47kSell |
| David Krempa | Chief Business Officer | 2026-01-14 | 1,942 | $15.62 | $30.33kSell |
| Sean Brynjelsen | President CEO | 2026-01-01 | 5,015 | $15.39 | $77.18kSell |
| James R. Gruber | Chief Financial Officer | 2025-12-12 | 4,542 | $16.99 | $77.17kSell |
| Ipek Erdogantrinkaus | Chief Commercial Officer | 2025-12-12 | 85 | $16.90 | $1.44kSell |
| David Krempa | Chief Business Officer | 2025-12-12 | 6,264 | $17.00 | $106.49kSell |
| Sean Brynjelsen | President CEO | 2025-12-12 | 6,732 | $16.83 | $113.30kSell |
ETON insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ETON insiders and whales buy or sell their stock.
ETON Shareholders
What type of owners hold Eton Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Opaleye Management Inc | 10.72% | 2,937,070 | $88.88M | Insider |
| Sean Brynjelsen | 10.64% | 2,914,206 | $88.18M | Insider |
| Opaleye Management Inc | 10.44% | 2,860,000 | $86.54M | Institution |
| Ecor1 Capital LLC | 7.93% | 2,171,938 | $65.72M | Institution |
| Harrow Health Inc | 7.24% | 1,982,000 | $59.98M | Insider |
| Blackrock Inc | 6.27% | 1,717,286 | $51.97M | Institution |
| Nantahala Capital Management LLC | 4.29% | 1,175,951 | $35.58M | Institution |
| Vanguard Capital Management LLC | 3.63% | 994,089 | $30.08M | Institution |
| David Krempa | 2.30% | 630,238 | $19.07M | Insider |
| Geode Capital Management LLC | 2.11% | 577,666 | $17.48M | Institution |
ETON vs Pharmaceutical Stocks
Eton Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.